Litcius/Paper detail

Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressiva

Thomas Ullrich, Luca Arista, Sven Weiler, Sylvie Teixeira‐Fouchard, Valérie Broennimann, Nikolaus Stiefl, Victoria Head, Ina Krämer, Sabine Guth

2022Bioorganic & Medicinal Chemistry Letters10 citationsDOIOpen Access PDF

Topics & Concepts

Fibrodysplasia ossificans progressivaChemistryADMEActivin receptorKinaseIn vitroPharmacologyReceptorHeterotopic ossificationBiochemistryMedicineAnatomyHeterotopic Ossification and Related ConditionsMedical Imaging and Pathology StudiesParathyroid Disorders and Treatments
Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressiva | Litcius